This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Applied Stemcell, Inc.. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Guoliang Yu: Innovator in Gene Expression Technology
Introduction
Guoliang Yu is a prominent inventor based in Hillsborough, California. He has made significant contributions to the field of gene expression, particularly through his innovative approaches to enhancing the expression of exogenous genes.
Latest Patents
Guoliang Yu holds a patent for an invention titled "Enhanced Gene Expression." This patent presents a novel method for expressing exogenous genes at increased levels by incorporating them into regions of increased gene expression (RIDGE) on a chromosome of a host cell. The method involves identifying RIDGE(s) and integrating integrase-specific sites, which leads to high levels of gene expression. This approach not only ensures predictability in the location of the exogenous genes but also eliminates genetic instability and reduces the time and cost associated with optimizing protein production in host cells. The implications of this technology are significant for the production of therapeutic, prophylactic, and diagnostic proteins.
Career Highlights
Guoliang Yu is currently employed at Applied Stemcell, Inc., where he continues to advance his research in gene expression technologies. His work has positioned him as a key figure in the field, contributing to the development of innovative solutions that have the potential to transform therapeutic applications.
Collaborations
Guoliang collaborates with James Zhu, a fellow researcher, to further explore and develop advancements in gene expression technologies.
Conclusion
Guoliang Yu's innovative work in enhancing gene expression represents a significant advancement in biotechnology. His contributions are poised to have a lasting impact on the production of essential proteins for therapeutic use.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile